These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18613191)

  • 1. A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging.
    Choi JS; Park JC; Nah H; Woo S; Oh J; Kim KM; Cheon GJ; Chang Y; Yoo J; Cheon J
    Angew Chem Int Ed Engl; 2008; 47(33):6259-62. PubMed ID: 18613191
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Two is better than one'--probes for dual-modality molecular imaging.
    Jennings LE; Long NJ
    Chem Commun (Camb); 2009 Jun; (24):3511-24. PubMed ID: 19521594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards multimodal nanoparticle labels for molecular imaging of biological processes.
    Babinec P; Babincová M
    Med Hypotheses; 2007; 69(3):703-4. PubMed ID: 17329036
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
    Cheon J; Lee JH
    Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments of magnetic resonance imaging and spectroscopy in the field of molecular imaging.
    Aime S; Bisi G
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):563-4. PubMed ID: 20016449
    [No Abstract]   [Full Text] [Related]  

  • 6. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging.
    Yang F; Li Y; Chen Z; Zhang Y; Wu J; Gu N
    Biomaterials; 2009 Aug; 30(23-24):3882-90. PubMed ID: 19395082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoprobes for hybrid SPECT/MR molecular imaging.
    Misri R; Saatchi K; Häfeli UO
    Nanomedicine (Lond); 2012 May; 7(5):719-33. PubMed ID: 22630153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes.
    Aime S; Delli Castelli D; Terreno E
    Angew Chem Int Ed Engl; 2005 Aug; 44(34):5513-5. PubMed ID: 16052647
    [No Abstract]   [Full Text] [Related]  

  • 9. Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems.
    Cheng CM; Chu PY; Chuang KH; Roffler SR; Kao CH; Tseng WL; Shiea J; Chang WD; Su YC; Chen BM; Wang YM; Cheng TL
    Cancer Gene Ther; 2009 Jan; 16(1):83-90. PubMed ID: 18802451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging I. Preface.
    Semmler W; Schwaiger M
    Handb Exp Pharmacol; 2008; (185 Pt 1):vii-ix. PubMed ID: 18763375
    [No Abstract]   [Full Text] [Related]  

  • 11. Tailor-made quantum dot and iron oxide based contrast agents for in vitro and in vivo tumor imaging.
    Pöselt E; Schmidtke C; Fischer S; Peldschus K; Salamon J; Kloust H; Tran H; Pietsch A; Heine M; Adam G; Schumacher U; Wagener C; Förster S; Weller H
    ACS Nano; 2012 Apr; 6(4):3346-55. PubMed ID: 22463104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelator-free synthesis of a dual-modality PET/MRI agent.
    Chen F; Ellison PA; Lewis CM; Hong H; Zhang Y; Shi S; Hernandez R; Meyerand ME; Barnhart TE; Cai W
    Angew Chem Int Ed Engl; 2013 Dec; 52(50):13319-23. PubMed ID: 24166933
    [No Abstract]   [Full Text] [Related]  

  • 13. Gd3+-functionalized near-infrared quantum dots for in vivo dual modal (fluorescence/magnetic resonance) imaging.
    Jin T; Yoshioka Y; Fujii F; Komai Y; Seki J; Seiyama A
    Chem Commun (Camb); 2008 Nov; (44):5764-6. PubMed ID: 19009074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc ferrite nanoparticles as MRI contrast agents.
    Bárcena C; Sra AK; Chaubey GS; Khemtong C; Liu JP; Gao J
    Chem Commun (Camb); 2008 May; (19):2224-6. PubMed ID: 18463747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging: The latest generation of contrast agents and tissue characterization techniques.
    Blankenberg FG
    J Cell Biochem; 2003 Oct; 90(3):443-53. PubMed ID: 14523978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality cardiovascular molecular imaging, part I.
    Sinusas AJ; Bengel F; Nahrendorf M; Epstein FH; Wu JC; Villanueva FS; Fayad ZA; Gropler RJ
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):244-56. PubMed ID: 19808549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotubular paramagnetic probes as contrast agents for magnetic resonance imaging based on the diffusion tensor.
    Negri V; Cerpa A; López-Larrubia P; Nieto-Charques L; Cerdán S; Ballesteros P
    Angew Chem Int Ed Engl; 2010 Mar; 49(10):1813-5. PubMed ID: 20140928
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
    Amstad E; Zurcher S; Mashaghi A; Wong JY; Textor M; Reimhult E
    Small; 2009 Jun; 5(11):1334-42. PubMed ID: 19242944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive cell tracking.
    Kiessling F
    Handb Exp Pharmacol; 2008; (185 Pt 2):305-21. PubMed ID: 18626608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.